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Selenium is an essential trace elementwith potent cancer preven-
tion activity in mammals. The 15-kDa selenoprotein (Sep15) has
been implicated in the chemopreventive effect of dietary selenium.
Although the precise function of Sep15 remains elusive, Sep15 co-
purifies with UDP-glucose:glycoprotein glucosyltransferase (GT),
an essential regulator of quality control mechanisms within the
endoplasmic reticulum. Recent studies identified two GT and two
Sep15 homologues in mammals. We characterize interactions
between these protein families in this report. Sep15 and GT form a
tight 1:1 complex, and these interactions are conserved between
mammals and fruit flies. In mammalian cells, Sep15 co-immuno-
precipitates with both GT isozymes. In contrast, a Sep15 homo-
logue, designated selenoproteinM (SelM), does not form a complex
with GT. Sequence analysis of members of the Sep15 family identi-
fied a novelN-terminal cysteine-rich domain in Sep15 that is absent
in SelM. This domain contains six conserved cysteine residues that
form two CxxC motifs that do not coordinate metal ions. If this
domain is deleted or the cysteines aremutated, Sep15 no longer forms
a complexwithGT.Conversely, if the cysteine-richdomainof Sep15 is
fused to the N-terminus of SelM, the resulting chimera is capable of
binding GT. These data indicate that the cysteine-rich domain of
Sep15 exclusivelymediates protein-protein interactions with GT.
Selenium is present in 25 human proteins in the form of selenocys-
teine, which is the 21st natural amino acid in the genetic code and is
encoded by the UGA codon (1, 2). Recent studies provide strong evi-
dence that dietary selenium supplements reduce the incidence of cancer
in animalmodels and human clinical trials (3–5). Lowmolecular weight
selenium compounds and selenium-containing proteins have been
implicated in this chemopreventive effect. However, the mechanism by
which selenium suppresses tumor development remains to be
established.
One candidate protein thatmaymediate the chemopreventive effects
of selenium is the 15-kDa selenoprotein (Sep15)3 (6, 7). The Sep15 gene
is located at position p31 on human chromosome 1. This region has
been shown to undergo loss of heterozygosity, which is frequently asso-
ciated with tumor progression, suggesting a potential tumor suppressor
role for this selenoprotein (8, 9). In addition, two polymorphisms found
at positions 811 (C/T) and 1125 (G/A), the latter of which is located
within the selenocysteine insertion sequence element, have been iden-
tified within the 3-untranslated region of the human Sep15 gene. The
nucleotide identity at these polymorphic sites has been shown to influ-
ence the efficiency of selenocysteine incorporation in a selenium-de-
pendent manner (10).
The precise biological function of Sep15 has not been firmly estab-
lished; however, this selenoprotein co-purifies with the essential regu-
lator of the calnexin cycle designated UDP-glucose:glycoprotein glu-
cosyltransferase (GT) (11). The calnexin cycle is a quality control
pathway localized to the endoplasmic reticulum that specifically assists
in the folding of N-linked glycoproteins (12). Once a newly synthesized
protein enters the endoplasmic reticulum, a glycan core of 14-oligosac-
charides (Glc3Man9GlcNAc2) is covalently linked to appropriate aspar-
agine residues. N-Linked glycoproteins are immediately recognized by
glucosidase I and II, the first components of the calnexin cycle, which
sequentially trim the two outermost glucose moieties from the glycan
core (13). Once processed, membrane-bound calnexin and its lumenal
homologue calreticulin bind to the glycan (14–17). This triggers the
binding of ERp57 (a lumenal protein disulfide isomerase) to calnexin
and calreticulin and accelerates folding by catalyzing disulfide bond
exchange (18–22). Regardless of the folded status of the bound glyco-
protein, glucosidase II cleaves the remaining glucose residue and the
complex disassociates, releasing the glycoprotein. If the glycoprotein is
properly folded, it is rapidly exported from the endoplasmic reticulum
by vesicular transport to the Golgi complex. Misfolded proteins are
re-glucosylated by GT, a 175-kDa lumenal enzyme that catalyzes the
transfer of a glucose moiety fromUDP-glucose to the distal mannose of
the glycan core (23). This event creates a retention signal that re-ini-
tiates the calnexin cycle.
In this quality control pathway, GT functions as the folding sensor
that assesses the folded status of glycoproteins. Although we do not
understand how GT senses structural fidelity, several important clues
have been revealed. (i) Sensing involves the innermost (and normally
buried) N-GlcNAc glycosidic bond of the glycoprotein (24, 25). (ii) GT
preferentially monoglucosylates partially folded late folding intermedi-
ates as compared with their fully denatured counterparts (26–28). (iii)
GT is capable of distinguishing folded frommisfolded domains within a
single polypeptide (29, 30). (iv) Localized folding defects in otherwise
correctly folded glycoproteins or individual domains are recognized by
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GT (30, 31). (v) GT monitors the tertiary and quaternary structures of
glycoproteins (32).
Given the sequence diversity of glycoproteins, it is unlikely that the
recognition mechanism used by GT involves a specific primary struc-
ture motif. A more robust mechanism, involving common biophysical
properties of misfolded proteins, seems more plausible. Accordingly,
the distribution of glycans and their spatial relationship to normally
surface-inaccessible hydrophobic residues influence the order in which
polypeptide segments achieve their native conformation (12, 27, 28).
GT preferentially recognizes hydrophobic motifs proximal to glycosy-
lation sites in glycopeptides (33). The efficiency of glucosylation can be
positively correlated with the spatial proximity of site-directed muta-
tions to each glycan, lending support to the idea that normally buried
hydrophobic residues found adjacent to glycans mediate interactions
with GT (31).
Our initial findings of the interaction betweenmammalian Sep15 and
GT (11) raised the possibility that Sep15might be amisfolded glycopro-
tein. Although Sep15 does not contain an endoplasmic reticulum reten-
tion sequence, it is neither secreted or glycosylated, suggesting that this
selenoprotein might function as a co-factor that assists GT in assessing
structural fidelity. Sep15 deficiencies observed in tumors may also
impair GT-mediated regulation of the calnexin cycle.
In this report, we characterize interactions between members of
Sep15 and GT protein families. Isothermal titration calorimetry was
used to demonstrate that Sep15 forms a 1:1 complex with GT with an
apparent Kd value of 20 nM. Moreover, co-immunoprecipitation
revealed that Sep15 binds to both human GT isozymes. Although sel-
enoproteinM (SelM) shares significant sequence homology with Sep15
and has also been localized to the endoplasmic reticulum, it does not
form a complex with GT. The interaction between Sep15 and GT is
exclusively mediated by a novel cysteine-rich domain located at the
N-terminus of Sep15. This conserved domain is present in other func-
tional Sep15 homologues and contains six conserved cysteine residues
that do not coordinate metal ions. When the cysteine-rich domain of
Sep15 is removed, it no longer forms a complex with GT. Site-directed
mutagenesis was used to demonstrate that the structural integrity of the
cysteine-rich domain is an essential factor in the ability of Sep15 to
bind GT.
EXPERIMENTAL PROCEDURES
Plasmids—Genes encoding Mus musculus Sep15 and SelM were
PCR amplified from cDNA clones using the following primers: 5-CA-
TTAGTATCTAATCTCGAGGGCAGACCGCAGGGAT-3 and 5-
CTCGAGGGATACTCTAGAGCG-3 (Sep15) and 5-ATCTCGAG-
ATGAGCATCCTACTGTCGCCGCCGTC-3 and 5-ATGCGGCC-
GCTACAGGTCGTCGTGTTCTGAAGCTTCCTCG-5 (SelM). Both
PCR products were digested with XhoI and NotI and ligated into the
pCI-neo vector (Promega). The QuikChange site-directed mutagenesis
kit (Stratagene) was used to mutate these genes. The following mutag-
enic primers were used to replace naturally occurring selenocysteine
residues: U93C (5-CTTGAAGTCTGCGGATGTAAATTGGGGAG-
GTTCC-3 and 5-GGAACCTCCCCAATTTACATCCGCAGACT-
TCAAG-3) (designated Sep15-U93C) and U48C (5-GACCTGTGG-
AGGATGTCAGTTGAATCGC-3 and 5-GCGATTCAACTGACA-
TCCTCCACAGGTC-3) (designated SelM-U48C). Expected se-
quence changes were verified by DNA sequencing. Sep15-U93C served
as the template to introduce a C-terminal hexahistidine-tag with the
following primers: 5-CATTAGTATCTAATCTCGAGGGCAGACC-
GCAGGGAT-3 and 5-TCGAATTCTCAGTGGTGGTGGTGGTG-
GTGTATGCGTTCCAACTTCTCGCTC-3. The PCR product was
digested with XhoI and EcoRI and ligated into the pCI-neo vector.
Site-directed mutagenesis of His-tagged Sep15-U93C was performed
with the following mutagenic primers: Sep15-C38SU93C (5-GTTTG-
CGTCAGAGGCATCCAGAGAGTTGGGTTTC-3 and 5-GAAACC-
CAACTCTCTGGATGCCTCTGACGCAAAC-3), Sep15-C49SU93C
(5-CCAGCAACTTGCTCTCCAGCTCTTGCGATC-3 and 5-GATC-
GCAAGAGCTGGAGAGCAAGTTGCTGG-3), Sep15-C52SU93C
(5-CTCTGCAGCTCTTCCGATCTTCTTGGAC-3 and 5-GTCC-
AAGAAGATCGGAAGAGCTGCAGAG-3), Sep15-C67SU93C (5-
CACTGGACCCTGTTTCCAGAGGGTGCTGTC-3 and 5-GACA-
GCACCCTCTGGAAACAGGGTCCAGTG-3), Sep15-C70SU93C
(5-GTTTGCAGAGGGTCCTGTCAGGAAGAAG-3 and 5-CTTC-
TTCCTGACAGGACCCTCTGCAAAC-3), Sep15-C71SU93C (5-G-
CAGAGGGTGCTCTCAGGAAGAAGC-3 and 5-GCTTCTTCC-
TGAGAGCACCCTCTGC-3). Expected sequence changes were
verified by DNA sequencing.
A fusion protein of Sep15 and SelM from mouse (designated
Sep15::SelM)was generated by fusing the cysteine-rich domain of Sep15
to theN-terminus of SelM.The cysteine-rich domain of Sep15, together
with its native signal peptide, was PCR amplified using the following
primers: 5-TATAGACTAGACTCGAGGGCAGACCGCAG-3 and
5-GCAGACTTCAAGGATGAATTCTGCATACAGCTTTTTGG-
3. This PCR product was digested with XhoI and EcoRI and ligated into
the pCI-neo vector. SelM-U48C was PCR amplified without its signal
peptide using the following primers: 5-CTTGTGGCTCCAGC-
CGAATTCACCACCAACTACCGACC-3 and 5-ATGCGGCCGC-
TACAGGTCGTCGTGTTCTGAAGCTTCCTCG-3. The PCR prod-
uct was digested with EcoRI and NotI and ligated into the pCI-neo
vector containing the cysteine-rich domain of Sep15.
Mammalian expression vectors encoding protein C (PC)-tagged
human GT1 and GT2 have been described previously (34). The gene
encoding Sep15 fromDrosophilamelanogasterwas PCR amplified from
an expressed sequence tag clone using the following primers: 5-TGC-
TCGAGCAAATTGGCGCCGAATTGACGGCCGCCGACTG-3
and 5-CAGTTTTGGGTATGGGTACCTTAGATCCTGTTGGTT-
CGCAGG-3. The PCR product was digested with EheI and KpnI and
ligated into Baculovirus expression vector pFastBac-HTa (Invitrogen).
A previously described cDNAclone (35) served as the template to intro-
duce a C-terminal hexahistidine-tag into Drosophila GT. To improve
secretion from insect cells the native signal sequence was replaced with
the honeybee melittin signal peptide. Moreover, the C-terminal endo-
plasmic reticulum retention sequence was removed. Primer sequences
are available upon request.
Cell Growth, Transfection, and Immunoprecipitation—Mouse fibro-
blast cell line NIH 3T3 was grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum to 80% confluence.
Transfections were performed using Lipofectamine and PLUS reagent
(Invitrogen) according to manufacturer’s instructions. For each 60-mm
plate, 2 g of DNA, 8 l of PLUS reagent, and 12 l of Lipofectamine
were used. Protein extracts were prepared 48 h following transfection
with 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM CaCl2, 1% Igepal
CA-630 detergent, 0.5% deoxycholate, and EDTA-free complete prote-
ase inhibitor mixture tablets (Roche Applied Science). Once cleared of
cellular debris, cell lysates were incubated overnight with 50 l of
anti-PC affinity matrix (Roche Applied Science) at 4 °C. Bound proteins
were washed twice with 1ml of 50mMTris-HCl (pH 7.5), 150mMNaCl,
1 mM CaCl2, 1% Igepal CA-630 detergent, and 0.5% deoxycholate and
once with 1 ml of 50 mMTris-HCl (pH 7.5), 250 mMNaCl, 1 mMCaCl2,
0.1% Igepal CA-630 detergent, and 0.05% deoxycholate. Proteins were
eluted with 100l of 20mMTris-HCl (pH 7.5), 100mMNaCl, and 5mM
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EDTA. Samples were resolved by SDS-PAGE and detected by Western
blotting using anti-His-tag, anti-PC, anti-Sep15, and anti-SelM
antibodies.
Native Gel Electrophoresis—RecombinantDrosophila Sep15 and GT
proteins were expressed in Sf9 cells and purified by immobilized metal-
affinity chromatography. Complexes of Sep15 andGTwere prepared by
incubating 5g of GT dissolved in 10mMTris-HCl (pH 7.5) and 10mM
CaCl2 with the indicated amounts of Sep15 for 10min at 37 °C. Samples
were subjected to non-denaturing PAGE using Tris-glycine gels
(Invitrogen) and transferred to polyvinylidene difluoride membranes.
The Sep15-GT complexwas visualized byWestern blottingwith Sep15-
specific antibodies.
Isothermal Titration Calorimetry—The apparent association con-
stant for Sep15 binding to GT was determined using isothermal titra-
tion calorimetry. Protein solutions of Drosophila Sep15 and GT were
dialyzed for 2 days against 25 mMTris-HCl (pH 7.5), 200 mMNaCl, and
1 mM CaCl2. The concentrations of both proteins were determined
using Beer’s law. This experiment consisted of a series of 8-l injections
of Sep15 into a cell containing 1.4 ml of GT equilibrated at 20 °C. Heats
associated with Sep15 binding to GT were measured by an isothermal
titration calorimeter (Microcal). The apparent association constant
derived from these data were determined using software included with
the calorimeter.
Metal Ion Analysis—The concentrations of twenty biologically rele-
vant metal ions were determined by inductively coupled argon plasma
emission spectrometry at the Chemical Analysis Laboratory, University
of Georgia. Protein samples dissolved in 50 mM sodium phosphate (pH
7.0), 300 mM NaCl, and 250 mM imidazole were analyzed. Metal ion
concentrations were calculated by subtracting the ion content of the
buffer from that of the protein sample.
RESULTS
Sep15, but Not SelM, Interacts with Human GT Homologues—Sep15
is a resident protein of the endoplasmic reticulum that has been previ-
ously shown to form a complex with GT when purified from rat and
mouse liver (11). Two human GT homologues (GT1 and GT2) have
been identified (36). These enzymes are highly homologous and display
83% sequence identity in their proposed C-terminal catalytic domains.
However, their N-terminal non-catalytic domains are more diverse
(49% sequence identity), and only GT1 displays measurable catalytic
activity. To assess whether Sep15 functions as a protein co-factor that
binds both GT isozymes, mouse Sep15 was co-expressed with
PC-tagged GT1 or GT2 in NIH 3T3 cells. Sep15 co-immunoprecipi-
tated with GT1 and GT2 (Fig. 1A), indicating that both human GT
isozymes are capable of binding Sep15 in vivo. The reduced intensity of
the Sep15 signal observed with GT2 is consistent with its lower level of
expression as compared with that of GT1.
The recently described selenoprotein SelM (37) shares 31% sequence
identity with Sep15 (Fig. 2, A and B). Both proteins encode a single
selenocysteine residue. Primary sequence alignments illustrate that
SelM has an elongated C terminus, whereas Sep15 possesses an
extended cysteine-rich N terminus. The N-terminal sequence of Sep15
is conserved among functional Sep15 homologues and is conversely
absent in sequence homologues of SelM (Fig. 2C). As observed with
Sep15, selenoprotein SelM is also localized to the endoplasmic reticu-
lum. Given the common intracellular location of Sep15 and SelM and
their respective sequence homology, we speculated that SelM might
also bind to GT. However, co-immunoprecipitation experiments indi-
cate that mouse SelM does not form a complex with either human GT1
or GT2 (Fig. 1B).
Cysteine-rich Domain of Sep15 Mediates the Interaction with GT—
The absence of an N-terminal extension in SelM suggested that this
region of Sep15 may potentially mediate protein-protein interactions
withGT.To test this hypothesis, the cysteine-richN-terminal extension
of mouse Sep15 was fused to the N terminus of mouse SelM. When
expressed in NIH 3T3 cells, this mouse protein chimera co-immuno-
precipitates with human GT1 (Fig. 3). These data suggest a functional
role for theN-terminal extension of Sep15 in the formation of a complex
with GT.
Sequence analyses of the N-terminal domain of Sep15 proteins iden-
tified six conserved cysteine residues (Fig. 2C). Four of these six cysteine
residues form a pair of CxxC motifs. To establish a structural and/or
functional role for these cysteine residues and evaluate their potential
involvement in constituting the GT-binding site, all cysteine residues
were individually replaced with serine residues. Co-immunoprecipita-
tion experiments demonstrate that formation of the Sep15-GT complex
was abolished for each mutant (Fig. 4). These data indicate that the
N-terminal extension of Sep15 forms a distinct cysteine-rich domain
and that the structural integrity of this domain is required for Sep15 to
form a complex with GT.
FIGURE 1. Sep15, but not SelM, forms complexes with GT1 and GT2. A, NIH 3T3 cells
were co-transfected with plasmid-encodedmouse Sep15 and the empty control vector
pED or plasmids encoding either PC-tagged human GT1 (GT1-PC) or PC-tagged human
GT2 (GT2-PC). Proteins were immunoprecipitated (IP) using anti-PC antibodies, resolved
by SDS-PAGE, and detected byWestern blotting (WB) with anti-PC (upper left panel) and
anti-Sep15 (upper right panel) antibodies. In addition, prior to immunoprecipitation cell
lysateswere analyzedbyWesternblottingusing anti-PC (lower left panel) and anti-Sep15
(lower right panel) antibodies.B, NIH3T3 cellswere co-transfectedwithplasmid-encoded
mouse SelM and the empty control vector pED or plasmids encoding either PC-tagged
human GT1 (GT1-PC) or PC-tagged human GT2 (GT2-PC). Proteins were immunoprecipi-
tatedusing anti-PC antibodies, resolvedby SDS-PAGE, anddetectedbyWesternblotting
with anti-PC (upper left panel) and anti-SelM (upper right panel) antibodies. In addition,
prior to immunoprecipitation cell lysates were analyzed by Western blotting using
anti-PC (lower left panel) and anti-SelM (lower right panel) antibodies.
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Sep15 andGT Form a 1:1 Complex—One technical obstacle to inves-
tigating protein-protein interaction between Sep15 and GT is the nat-
urally occurring selenocysteine residue encoded within the Sep15 gene.
Selenocysteine-containing proteins are frequently difficult to express
and purify. However, the Sep15 protein of Drosophila is not a seleno-
protein and encodes two cysteine residues in place of the CxU motif
(Fig. 2B). To examine the binding between Drosophila Sep15 and GT,
both recombinant proteins were expressed and purified from Sf9 cells.
Formation of the complex between Sep15 and GT was analyzed by
polyacrylamide gel electrophoresis under non-denaturing conditions
(Fig. 5). Western blotting using antibodies specific for Sep15 detected a
low molecular weight band corresponding to unbound Sep15 in addi-
tion to a higher molecular weight band that co-migrates with GT. Sev-
eral minor low molecular weight bands were also detected, indicating
that Sep15 may form homomultimers and/or is degraded under these
experimental conditions. The band intensity of the Sep15-GT complex
FIGURE 2. Sequence alignment of members of
the Sep15 family. A, schematic illustration of the
domain arrangement of Sep15 and SelM. Both sel-
enoproteins encode an N-terminal signal peptide
(colored black), one selenocysteine (U) residue
(colored red), and a common redox domain (col-
ored gray). The N-terminal extension of Sep15,
containing six strictly conserved cysteine residues
(colored blue) has been labeled as the GT-binding
domain. B, multiple sequence alignment of Sep15
and SelM proteins. Conserved residues are high-
lighted. The genetically encoded selenocysteine
residues and the corresponding cysteine residue
found in theDrosophila Sep15 protein are colored
red. C, multiple sequence alignment of the N-ter-
minal cysteine-rich domain of Sep15 proteins.
Conserved cysteine residues are highlighted.
FIGURE 3. The N-terminal domain of Sep15
mediates the interaction with GT. NIH 3T3 cells
were transfected with the empty control vector
pCI-neo or co-transfected with plasmid-encoded
mouse Sep15::SelM chimera and the empty con-
trol vector pED or plasmid-encoded PC-tagged
human GT1 (GT1-PC). Samples were immunopre-
cipitated (IP) using anti-PC antibodies. Cell lysates
and immunoprecipitated samples were resolved
by SDS-PAGE and detected by Western blotting
with anti-PC (left panel) and anti-SelM (right panel)
antibodies.
ANovel Domain of Sep15Mediates the Interaction with GT
37842 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 280•NUMBER 45•NOVEMBER 11, 2005
 at UNIV O
F NEBRASKA - Lincoln on O
ctober 10, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
continued to increase as the molar equivalents of Sep15 and GT were
increased from 0.2 to 2.0, at which point the amount of unbound and
GT-bound Sep15 became equivalent.
The stoichiometry of the Sep15-GT complex was precisely deter-
mined by isothermal titration calorimetry (Fig. 6). Sep15 forms a 1:1
complexwithGTwith an apparentKd value of 20 nM.Themixed species
Sep15::SelMchimera also bound tightly toGT (supplemental Fig. S1). In
contrast, no interactions were observed for SelM and Sep15 without its
N-terminal cysteine-rich domain. These isothermal titration calorime-
try results were confirmed by measuring the intensity of the strongest
methyl resonance by one-dimensional 15N-edited proton NMR spec-
troscopy (supplemental Fig. S2). A decrease in the strongest methyl
resonance intensity in the protonNMRspectrumof the proteinmixture
in comparison to the added strongest methyl resonance intensities of
the individual proteins indicates specific protein-protein interactions
(38). Consistent with co-immunoprecipitation and isothermal titration
calorimetry data, these NMR data indicate that both Sep15 and the
Sep15::SelM chimera form complexes with GT. Conversely, SelM and
Sep15 without its corresponding cysteine-rich domain do not bind to
GT. Taken together these complementary techniques demonstrate that
the cysteine-rich domain of Sep15mediates that formation of a tight 1:1
complex with GT.
Formation of the Sep15-GTComplex Is NotMediated by Coordinated
Metal Ions—Four of the six conserved cysteine residues in the cysteine-
rich domain of Sep15 form two CxxC motifs, which are typically
involved in metal ion coordination. To establish whether the cysteine-
rich domain of Sep15 does coordinate metal ions, we further analyzed
Drosophila Sep15. When expressed in bacterial or insect cells, purified
Sep15 protein was colorless. Moreover, UV-visible spectrophotometric
analysis revealed only a single peak centered at 280 nm, indicating the
absence of certain co-factors and iron-sulfur clusters. Sep15 protein
samples were also analyzed for the presence of twenty biologically rele-
vant metal ions by inductively coupled argon plasma emission spec-
trometry. Only Co2 was detected (0.24 molar equivalents), which is
most likely non-specifically bound during protein purification by
immobilized metal-affinity chromatography using cobalt-based resin.
These data suggest that the cysteine-rich domain itself does not coor-
dinate metal ions.
It has been previously reported that the catalytic activity of GT is
dependent upon the presence of divalent cations (preferably Ca2) (39).
Althoughmetal ions were not detected in Sep15 protein preparations, it
is possible that metal ions mediate the interaction between Sep15 and
GT. To address this possibility, complex formation between Sep15 and
GT was analyzed by polyacrylamide gel electrophoresis under non-de-
naturing conditions in the absence and presence of 1 mM Ca2, Cu2,
Fe2, and Zn2. However, the Sep15-GT complex was observed inde-
pendently of the presence of metal ions (data not shown). These results
indicate that formation of the Sep15-GT complex is not mediated by
coordinated metal ions.
Sep15 Does Not Affect Glucosylation of Thyroglobulin—The associa-
tion of Sep15 with GT suggests that this selenoprotein may modulate
the enzymatic activity of GT and/or be involved in assessing structural
fidelity. To test this hypothesis, GT activity in the presence of Sep15was
analyzed by monitoring the amount of incorporated [14C]glucose into
denatured thyroglobulin. The presence of Sep15 did not affect the GT
activity toward this protein (supplemental Fig. S3). These results indi-
cate that, at least in the case of thyroglobulin, Sep15 does not modulate
GT activity and is not required for glucosylation under these experi-
mental conditions.
DISCUSSION
Selenoproteins have not been previously shown to participate in the
quality control networks of the endoplasmic reticulum.The observation
that Sep15 co-purifies with the essential regulator of the calnexin cycle
FIGURE 4. Binding of Sep15 to GT is dependent upon the structural integrity of the
cysteine-rich domain. NIH 3T3 cells were co-transfected with plasmid-encoded PC-
tagged human GT1 (GT1-PC) and the empty control vector pCI-neo or plasmid-encoded
His-tagged mouse Sep15-U93C or Sep15-C38SU93C, Sep15-C49SU93C, Sep15-
C52SU93C, Sep15-C67SU93C, Sep15-C70SU93C, and Sep15-C71SU93C mutants. Sam-
ples were immunoprecipitated (IP) using anti-PC antibodies, resolved by SDS-PAGE, and
detected by Western blotting (WB) with anti-PC (first panel) and anti-His (second panel)
antibodies. Cell lysates were also directly probed using anti-PC (third panel) and anti-His
antibodies (fourth panel).
FIGURE 5. Stoichiometry of the Sep15-GT com-
plex fromD.melanogaster.A,Westernblot of the
Sep15-GT complex using antibodies specific for
Drosophila Sep15. B, Coomassie Blue staining of
the corresponding native gel. Samples were
resolved by PAGE under non-denaturing condi-
tions. For bothpanels: lane 1, GT; lanes 2–6, GTpre-
incubatedwith 5:1 (lane 2), 2:1 (lane 3), 1:1 (lane 4),
1:2 (lane 5), and 1:5 (lane 6) molar equivalents of
Sep15 to GT. Complexes of Sep15 and GT were
prepared by incubating of 5g of GT contained in
10mM Tris-HCl (pH 7.5) and 10mMCaCl2 with 0.11,
0.28, 0.56, 1.12, or 2.8 g of Sep15 for 10 min at
37 °C.
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suggests a potential mechanism for the chemopreventive effects of die-
tary selenium (11).
In this study, we characterized interactions between members of
Sep15 and GT families using a series of complementary genetic and
biophysical techniques and found that this selenoprotein interacts with
both humanGT isozymes. The 1:1 stoichiometry of this complex has an
apparent Kd value of 20 nM as determined by isothermal titration calo-
rimetry using Sep15 and GT from Drosophila. In contrast, SelM (a
sequence homologue of Sep15) does not interact with GT. Multiple
sequence analyses identified a novel cysteine-rich domain that is con-
served among theN termini of Sep15 proteins, which is not found in the
sequences of SelM proteins. If the cysteine-rich domain of Sep15 is
deleted, the truncated Sep15 protein no longer interacts with GT. How-
ever, when the cysteine-rich domain of Sep15 is fused to theN terminus
of SelM, the resulting Sep15::SelM protein chimera forms a complex
with GT.
The sequence of the cysteine-rich domain is highly conserved among
Sep15 homologues fromplants to humans (40) (Fig. 2C), suggesting that
interactions between Sep15 and GT have been conserved throughout
evolution. Mutating any one of these six conserved cysteine residues
disrupts the interaction between Sep15 and GT. As four of these six
cysteine residues form a pair of CxxC motifs, we speculated that these
motifs might coordinate metal ions, such as iron or zinc. However,
metal ion analysis of purified Sep15 protein samples did not identify
specifically bound metal ions. It is more likely that these conserved
cysteine residues form intramolecular disulfide bonds. Site-directed
mutagenesis of cysteine residuesmay disrupt the proper arrangement of
these disulfide bonds and compromise the structural integrity of the
cysteine-rich domain,which in turn inhibits protein-protein interaction
between Sep15 and GT. Taken together, these data unequivocally dem-
onstrate that the cysteine-rich domain mediates the interaction
between Sep15 andGT.However, the corresponding regions of GT that
are involved in forming the binding surface for Sep15 remain to be
established.
The fact that Sep15 does not possess the endoplasmic reticulum
retention signal and its N-terminal part is responsible for maintaining
Sep15 in the endoplasmic reticulum (41) suggests that its location in this
cellular compartment is the result of the interaction with GT.
The biological significance of protein-protein interactions between
Sep15 and GT within the endoplasmic reticulum is poorly understood.
One possibility is that Sep15 modulates the enzymatic activity of GT by
functioning as a protein co-factor that assists this folding sensor in
assessing the structural fidelity of misfolded glycoproteins. However,
our data show thatGT-mediated labeling of thyroglobulin is not directly
affected by Sep15. Sep15 appears to occur exclusively in the complex
with GT, whereas GT is present in both selenoprotein-bound and sel-
enoprotein-free form (11). Thus, it is possible that Sep15 is not required
for the GT function per se but may be required for the recognition of
glycoproteins with incorrectly formed disulfide bonds. It is an attractive
possibility that the unusual CxU motif of Sep15 may participate in the
reduction, isomerization, or oxidation of disulfide bonds of glycoprotein
substrates of GT.
Acknowledgments—We thank S. M. Arnold and R. J. Kaufman for providing
human GT expression constructs, D. Arac¸ and J. Rizo for their assistance with
NMR data collection, C. A. Brautigam for assistance with the collection and
analysis of isothermal titration calorimetry data, and J. Deisenhofer for advice
and access to equipment.
REFERENCES
1. Stadtman, T. C. (1996) Annu. Rev. Biochem. 65, 83–100
2. Kryukov, G. V., Castellano, S., Novoselov, S. V., Lobanov, A. V., Zehtab, O., Guigo, R.,
and Gladyshev, V. N. (2003) Science 300, 1439–1443
3. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J.,
Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L., Jr.,
Park, H. K., Sanders, B. B., Jr., Smith, C. L., and Taylor, J. R. (1996) J. Am. Med. Assoc.
276, 1957–1963
4. Zhang, Z., Kimura, M., and Itokawa, Y. (1997) Biol. Trace Elem. Res. 57, 147–155
5. Ip, C., Dong, Y., and Ganther, H. E. (2002) Cancer Metastasis Rev. 21, 281–289
6. Kumaraswamy, E., Malykh, A., Korotkov, K. V., Kozyavkin, S., Hu, Y., Kwon, S. Y.,
Moustafa, M. E., Carlson, B. A., Berry, M. J., Lee, B. J., Hatfield, D. L., Diamond, A.M.,
and Gladyshev, V. N. (2000) J. Biol. Chem. 275, 35540–35547
7. Apostolou, S., Klein, J. O.,Mitsuuchi, Y., Shetler, J. N., Poulikakos, P. I., Jhanwar, S. C.,
Kruger, W. D., and Testa, J. R. (2004) Oncogene 23, 5032–5040
8. Cheung, T. H., Chung, T. K., Poon, C. S., Hampton, G. M., Wang, V. W., andWong,
Y. F. (1999) Cancer 86, 1294–1298
9. Apostolou, S., De Rienzo, A., Murthy, S. S., Jhanwar, S. C., and Testa, J. R. (1999) Cell
97, 684–688
10. Hu, Y. J., Korotkov, K. V., Mehta, R., Hatfield, D. L., Rotimi, C. N., Luke, A., Prewitt,
T. E., Cooper, R. S., Stock, W., Vokes, E. E., Dolan, M. E., Gladyshev, V. N., and
Diamond, A. M. (2001) Cancer Res. 61, 2307–2310
11. Korotkov, K. V., Kumaraswamy, E., Zhou, Y., Hatfield, D. L., and Gladyshev, V. N.
(2001) J. Biol. Chem. 276, 15330–15336
12. Daniels, R., Kurowski, B., Johnson, A. E., andHebert, D.N. (2003)Mol. Cell 11, 79–90
13. Pelletier,M. F.,Marcil, A., Sevigny, G., Jakob, C. A., Tessier, D. C., Chevet, E.,Menard,
R., Bergeron, J. J., and Thomas, D. Y. (2000) Glycobiology 10, 815–827
14. Zapun, A., Petrescu, S.M., Rudd, P.M., Dwek, R. A., Thomas, D. Y., and Bergeron, J. J.
(1997) Cell 88, 29–38
FIGURE 6. Characterization of Sep15 binding to GT by isothermal titration calorim-
etry. The upper half of this panel shows the binding isotherm. The horizontal line repre-
sents the base line. The lower half of this panel shows the amount of heat derived from
each kcal/mol of injectant (Sep15). The curved line shows a fit of a single-site binding
model to the data. Protein concentrations of Drosophila Sep15 and GT were 104 and 7
M, respectively.
ANovel Domain of Sep15Mediates the Interaction with GT
37844 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 280•NUMBER 45•NOVEMBER 11, 2005
 at UNIV O
F NEBRASKA - Lincoln on O
ctober 10, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
15. Ellgaard, L., Riek, R., Herrmann, T., Guntert, P., Braun, D., Helenius, A., and Wuth-
rich, K. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 3133–3138
16. Schrag, J. D., Bergeron, J. J., Li, Y., Borisova, S., Hahn, M., Thomas, D. Y., and Cygler,
M. (2001)Mol. Cell 8, 633–644
17. Kapoor, M., Srinivas, H., Kandiah, E., Gemma, E., Ellgaard, L., Oscarson, S., Helenius,
A., and Surolia, A. (2003) J. Biol. Chem. 278, 6194–6200
18. Zapun, A., Darby, N. J., Tessier, D. C.,Michalak,M., Bergeron, J. J., and Thomas, D. Y.
(1998) J. Biol. Chem. 273, 6009–6012
19. Molinari, M., and Helenius, A. (1999) Nature 402, 90–93
20. Molinari, M., and Helenius, A. (2000) Science 288, 331–333
21. Frickel, E.M., Riek, R., Jelesarov, I., Helenius, A.,Wuthrich, K., and Ellgaard, L. (2002)
Proc. Natl. Acad. Sci. U. S. A. 99, 1954–1959
22. Leach, M. R., Cohen-Doyle, M. F., Thomas, D. Y., and Williams, D. B. (2002) J. Biol.
Chem. 277, 29686–29697
23. Hebert, D. N., Foellmer, B., and Helenius, A. (1995) Cell 81, 425–433
24. Sousa, M. C., Ferrero-Garcia, M. A., and Parodi, A. J. (1992) Biochemistry 31, 97–105
25. Sousa, M., and Parodi, A. J. (1995) EMBO J. 14, 4196–4203
26. Trombetta, E. S., and Helenius, A. (2000) J. Cell Biol. 148, 1123–1129
27. Caramelo, J. J., Castro, O. A., Alonso, L. G., De Prat-Gay, G., and Parodi, A. J. (2003)
Proc. Natl. Acad. Sci. U. S. A. 100, 86–91
28. Caramelo, J. J., Castro, O. A., de Prat-Gay, G., and Parodi, A. J. (2004) J. Biol. Chem.
279, 46280–46285
29. Ritter, C., and Helenius, A. (2000) Nat. Struct. Biol. 7, 278–280
30. Ritter, C., Quirin, K., Kowarik, M., and Helenius, A. (2005) EMBO J. 24, 1730–1738
31. Taylor, S. C., Ferguson, A. D., Bergeron, J. J., and Thomas, D. Y. (2004) Nat. Struct.
Mol. Biol. 11, 128–134
32. Keith, N., Parodi, A. J., and Caramelo, J. J. (2005) J. Biol. Chem. 280, 18138–18141
33. Taylor, S. C., Thibault, P., Tessier, D. C., Bergeron, J. J., and Thomas, D. Y. (2003)
EMBO Rep. 4, 405–411
34. Arnold, S. M., and Kaufman, R. J. (2003) J. Biol. Chem. 278, 43320–43328
35. Parker, C. G., Fessler, L. I., Nelson, R. E., and Fessler, J. H. (1995) EMBO J. 14,
1294–1303
36. Arnold, S. M., Fessler, L. I., Fessler, J. H., and Kaufman, R. J. (2000) Biochemistry 39,
2149–2163
37. Korotkov, K. V., Novoselov, S. V., Hatfield, D. L., and Gladyshev, V. N. (2002) Mol.
Cell. Biol. 22, 1402–1411
38. Arac¸, D., Murphy, T., and Rizo, J. (2003) Biochemistry 42, 2774–2780
39. Trombetta, S. E., and Parodi, A. J. (1992) J. Biol. Chem. 267, 9236–9240
40. Gladyshev, V. N., Jeang, K. T., Wootton, J. C., and Hatfield, D. L. (1998) J. Biol. Chem.
273, 8910–8915
41. Kumaraswamy, E., Korotkov, K. V., Diamond, A. M., Gladyshev, V. N., and Hatfield,
D. L. (2002)Methods Enzymol. 347, 187–197
ANovel Domain of Sep15Mediates the Interaction with GT
NOVEMBER 11, 2005•VOLUME 280•NUMBER 45 JOURNAL OF BIOLOGICAL CHEMISTRY 37845
 at UNIV O
F NEBRASKA - Lincoln on O
ctober 10, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
 17
Supplemental Data 
 
EXPERIMENTAL PROCEDURES 
 
Plasmids – The coding regions of SelM from M. musculus and Sep15 from D. melanogaster were PCR 
amplified from a cDNA clone (1) and a cDNA library (Clontech) with the following primers: 5'-
TCCAGCCACCCATATGACCAACTACCGACCGGATTGGAACC-3' and 5'-
GGTGGTGGTGCTCGAGGTCGTCGTGTTCTGAAGCTTCCTC-3' (residues 25-145 of SelM-U48C 
with a C-terminal hexahistidine-tag); and 5'-
ATTCCATGGGACATCACCATCACCATCTCGAGCAAATTCAA-3' and 5'-
ACCCCCATGGTTAGATCCTGTTGGT-3' (residues 16-178 of Sep15 with an N-terminal hexahistidine-
tag). The resulting PCR fragments were digested with NdeI and XhoI or NcoI, and ligated into expression 
vectors pET21a or pET19b (Novagen). Sep15 without its N-terminal cysteine-rich domain (designated 
∆Cys-Sep15) was subcloned with the following primers: 5'-
AAGGGCTAGCCACCATCACCATCACCATTTGGATCAGCAGCCG-3' and 5'-
AAGGCTCGAGTTAGATCCTGTTGGT-3' (residues 62-178 of Sep15 with an N-terminal hexahistidine-
tag). The resulting PCR product was digested with NheI and XhoI, and ligated into expression vector 
pET19b. A chimera D. melanogaster Sep15 and M. musculus SelM (designated Sep15::SelM) was 
generated by fusing the cysteine-rich domain of Sep15 to the N-terminus of SelM-U48C. The cysteine-
rich domain of Sep15 (residues 16-61) was PCR amplified using the following primers: 5'-
AAGGCATATGCTCGAGCAAATTCAAA-3' and 5'-AAGGCATATGAGTGCAGCATTGCTTACA-3'. 
This PCR product was digested with NdeI, and ligated into the pET21a vector containing SelM (residues 
25-145 with a C-terminal hexahistidine-tag). Expected nucleotide sequences were verified by DNA 
sequencing. 
NMR spectroscopy – Uniformly 15N-labeled Sep15, Sep15 without its cysteine-rich domain (∆Cys-
Sep15), SelM, and the Sep15::SelM chimera were produced by supplementing M9 media with 1 g/l 15N-
ammonium chloride and 3 g/l glucose supplemented with 0.5 ml/l of 0.5% thiamine, 2 mM MgSO4, 0.1 
mM CaCl2, 0.5 ml/l of 10 mg/ml biotin, and 100 µg/ml of carbencillin. These proteins were expressed in 
Escherichia coli BL21(DE3) cells (Novagen). Cell cultures were grown at 37°C until the OD600 reached 
0.6. Protein expression was induced by adding 0.4 mM IPTG, and the cells were grown for 16 hours at 
30°C. Following induction, bacterial cells were harvested by centrifugation at 4,700g for 15 minutes at 
4°C, cell pellets were re-suspended in lysis buffer [50 mM Tris (pH 8.0), 150 mM NaCl, 0.1% Triton-X-
100, 10 mg/l lysozyme, 5 mg/l DNaseI, and EDTA-free Complete Protease Inhibitor Tablets (Roche)], 
and lysed by sonication. Cell lysates were centrifuged at 40,000g for 30 minutes at 4°C. Recombinant 
proteins were purified from cell lysates by immobilized metal-chelate affinity chromatography using Ni-
NTA agarose (Qiagen). All proteins were further purified by ion exchange and gel filtration 
chromatography using MonoQ and Superdex 75 columns (Amersham Biosciences), respectively. All 
NMR experiments were acquired at 25°C with Varian Inova spectrometers operating at proton 
frequencies of 500 and 600 MHz using 1 mM protein samples dissolved in 25 mM Tris (D11, 98%)(pH 
7.0), 200 mM NaCl, 1 mM CaCl2, and 5% D2O. Protein-protein interactions were monitored by one-
dimensional NMR using the strongest methyl resonance 15N-edited technique as described previously (2). 
Measurement of UDP-glucose:glycoprotein glucosyltransferase activity – The catalytic activity of GT 
was determined as described previously (3). Bovine thyroglobulin (20 mg/ml) was denatured for 16 h at 
room temperature in 5 mM Tris-HCl (pH 7.5) and 8 M urea. The protein solution was subsequently 
dialyzed against 25 mM Tris-HCl (pH 7.5) for four hours at 4ºC - the buffer was exchanged each hour. In 
a final volume of 50 µl, 0.5 µM GT contained in 10 mM CaCl2 and 10 mM Tris-HCl, was incubated with 
5 µM [14C]-UDP glucose (303 mCi/mmol - MP Biomedicals), 20 µM of denatured thyroglobulin and 4:1, 
2:1, 1:1, 1:2 and 1:10 molar equivalents of Sep15 to GT for 10 minutes at 37˚C. Samples were 
precipitated with 1 ml of cold 10% trichloroacetic acid for 30 minutes. Labeled thyroglobulin was 
collected on 24 mm GF/C glass microfiber filters, washed with 10 ml of cold 10% trichloroacetic acid, 1 
 18
ml of cold 100% ethanol, 1 ml of acetone, and dried. The amount of incorporated [14C]-glucose was 
quantified using a liquid scintillation counter. 
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Fig. S1. Characterization of binding to GT by isothermal titration calorimetry. A, Sep15; B, ∆Cys-
Sep15; C, SelM; and D, Sep15::SelM chimera. These panels show the binding isotherms. The horizontal 
line represents the baseline. 
 20
 
 
Fig. S2. Characterization of binding to GT by 1D NMR using the 15N-edited strongest methyl 
resonance technique. A, 5.8 µM 15N-labeled Sep15 (left) and following the addition of 13 µM GT 
(right). The resulting protein concentration was calculated to be 15.1 µM, indicating the formation of a 
complex. B, 3.7 µM 15N-labeled ∆Cys-Sep15 (left) and following the addition of 13 µM GT (right). The 
resulting protein concentration was calculated to be 16.7 µM, indicating that these two proteins do not 
interact. C, 5.0 µM 15N-labeled SelM (left) and following the addition of 13 µM GT (right). The resulting 
protein concentration was calculated to be 18.0 µM, indicating that these two proteins do not interact. D, 
3.3 µM 15N-labeled Sep15::SelM (left) and following the addition of 13 µM GT (right). The resulting 
protein concentration was calculated to be 13.0 µM, indicating the formation of a complex. 
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Fig. S3. Sep15 does not affect glucosylation of thyroglobulin. A, GT-catalyzed incorporation of [14C]-
glucose into denatured thyroglobulin as a function of time. B, Fold induction of GT activity as a function 
of the Sep15/GT molar ratio.  
